Ophthalmic Case Studies and Novel Approach

In a small randomized controlled trial, production of aqueous tears and secretion of goblet cells increased following application of the Oculeve Intranasal Lacrimal Neurostimulator (Allergan).1 This handheld device works by delivering electrical stimulation to the anterior ethmoidal branch of the trigeminal nerve in the nasal cavities. It potentially offers a new mechanism for treating dry eye disease—now largely managed with artificial tears and anti-inflammatory agents.

    Related Conference of Ophthalmic Case Studies and Novel Approach

    November 14 - 15, 2019

    33rd European Ophthalmology Congress

    Madrid, Spain

    Venue: Rafael Hoteles forum Alcala
    November 14-15, 2019

    20th Global Ophthalmologists Annual Meeting

    Amsterdam, Netherlands
    November 19-20, 2019

    Global Opthalmologists Annual Meeting

    Johannesberg, South Africa
    December 05-06, 2019

    3rd World Congress on Eye and Vision

    Abu Dhabi, UAE
    December 09-10, 2019

    World Eye and Vision Congress

    Dubai, UAE
    February 19-20 2020

    4th International Conference on Ophthalmology

    Osaka, Japan
    March 02-03, 2020

    5thGlobal Pediatric Ophthalmology Congress

    Rome, Italy
    April 13-14, 2020

    World Congress on Ophthalmology & Optometry

    London, UK
    October 19-20, 2020

    19th Asia Pacific Ophthalmologists Annual Meeting

    | Singapore

    Ophthalmic Case Studies and Novel Approach Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in